Cerus
CERS
#7539
Rank
โ‚น35.82 B
Marketcap
โ‚น186.49
Share price
-1.43%
Change (1 day)
23.06%
Change (1 year)

Cerus (CERS) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น8.84 Billion

According to Cerus's latest financial reports the company's total debt is โ‚น8.84 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cerus - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น8.41 B5.3%
2023-12-31โ‚น7.99 B10.71%
2022-12-31โ‚น7.21 B10.73%
2021-12-31โ‚น6.51 B33.26%
2020-12-31โ‚น4.89 B6.44%
2019-12-31โ‚น4.59 B120.05%
2018-12-31โ‚น2.08 B9.77%
2017-12-31โ‚น1.90 B44.51%
2016-12-31โ‚น1.31 B0.04%
2015-12-31โ‚น1.31 B110.35%
2014-12-31โ‚น0.62 B200.87%
2013-12-31โ‚น0.20 B-50.83%
2012-12-31โ‚น0.42 B10.79%
2011-12-31โ‚น0.38 B74.07%
2010-12-31โ‚น0.21 B19592.9%
2009-12-31โ‚น1.11 M
2008-12-31N/A-100%
2007-12-31โ‚น1.25 M-75.56%
2006-12-31โ‚น5.13 M-97.7%
2005-12-31โ‚น0.22 B-86.78%
2004-12-31โ‚น1.68 B-33.58%
2003-12-31โ‚น2.54 B103878.76%
2002-12-31โ‚น2.44 M-38.19%
2001-12-31โ‚น3.95 M-26.92%
2000-12-31โ‚น5.41 M-14.7%
1999-12-31โ‚น6.34 M
1997-12-31โ‚น3.92 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Haemonetics
HAE
โ‚น110.34 B 1,147.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น49.73 M-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚น1.085 T 12,168.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚น23.06 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA